Publicacións (22) Publicacións de JUAN JOSE NIETO FONTARIGO

2024

  1. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666

2023

  1. Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 1, pp. 107-116.e4

  2. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial

    American journal of respiratory and critical care medicine, Vol. 207, Núm. 9, pp. 1161-1170

  3. C57Bl/6N mice have an attenuated lung inflammatory response to dsRNA compared to C57Bl/6J and BALB/c mice

    Journal of Inflammation (United Kingdom), Vol. 20, Núm. 1

  4. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  5. Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

    Open Respiratory Archives, Vol. 5, Núm. 4

  6. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2498-2508

  3. Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic

    The European respiratory journal, Vol. 60, Núm. 1

  4. Proteomic analysis of food allergens

    Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300

  5. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

    ERJ Open Research

2021

  1. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  2. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma

    Frontiers in Immunology, Vol. 12

2020

  1. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  2. iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183

2019

  1. Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics

    Scientific Reports, Vol. 9, Núm. 1

  2. Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

    International Journal of Clinical Practice, Vol. 73, Núm. 12

  3. CD26 and Asthma: a Comprehensive Review

    Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 2, pp. 139-160

2018

  1. Association between blood eosinophil count with asthma hospital readmissions

    European Journal of Internal Medicine, Vol. 53, pp. 34-39